메뉴 건너뛰기




Volumn 76, Issue 10, 2016, Pages 905-916

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA

Author keywords

alpha emitter; bone; chemotherapy; prostate; radium 223; safety

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ESTRAMUSTINE; HEMOGLOBIN; MITOXANTRONE; PLACEBO; RADIUM CHLORIDE RA 223; ANTINEOPLASTIC AGENT; RADIOISOTOPE; RADIUM; TAXOID;

EID: 84961836244     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23180     Document Type: Article
Times cited : (59)

References (16)
  • 1
    • 33746707858 scopus 로고    scopus 로고
    • High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: Adjuvant or alternative to conventional modalities
    • Bruland OS, Nilsson S, Fisher DR, Larsen RH. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: Adjuvant or alternative to conventional modalities? Clin Cancer Res 2006; 12:6250s–6257s.
    • (2006) Clin Cancer Res , vol.12 , pp. 6250s-6257s
    • Bruland, O.S.1    Nilsson, S.2    Fisher, D.R.3    Larsen, R.H.4
  • 2
    • 0036606104 scopus 로고    scopus 로고
    • Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model
    • Henriksen G, Breistol K, Bruland OS, Fodstad O, Larsen RH. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer Res 2002; 62:3120–3125.
    • (2002) Cancer Res , vol.62 , pp. 3120-3125
    • Henriksen, G.1    Breistol, K.2    Bruland, O.S.3    Fodstad, O.4    Larsen, R.H.5
  • 3
    • 0037315930 scopus 로고    scopus 로고
    • Targeting of osseous sites with alpha-emitting 223Ra: Comparison with the beta-emitter 89Sr in mice
    • Henriksen G, Fisher DR, Roeske JC, Bruland OS, Larsen RH. Targeting of osseous sites with alpha-emitting 223Ra: Comparison with the beta-emitter 89Sr in mice. J Nucl Med 2003; 44:252–259.
    • (2003) J Nucl Med , vol.44 , pp. 252-259
    • Henriksen, G.1    Fisher, D.R.2    Roeske, J.C.3    Bruland, O.S.4    Larsen, R.H.5
  • 11
    • 84908594586 scopus 로고    scopus 로고
    • Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: A prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
    • Hoskin P, Sartor O, O'Sullivan JM, Johannessen DC, Helle SI, Logue J, Bottomley D, Nilsson S, Vogelzang NJ, Fang F, Wahba M, Aksnes AK, Parker C. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: A prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial. Lancet Oncol 2014; 15:1397–1406.
    • (2014) Lancet Oncol , vol.15 , pp. 1397-1406
    • Hoskin, P.1    Sartor, O.2    O'Sullivan, J.M.3    Johannessen, D.C.4    Helle, S.I.5    Logue, J.6    Bottomley, D.7    Nilsson, S.8    Vogelzang, N.J.9    Fang, F.10    Wahba, M.11    Aksnes, A.K.12    Parker, C.13
  • 14
    • 77954313173 scopus 로고    scopus 로고
    • Anemia in men with advanced prostate cancer: Incidence, etiology, and treatment
    • Nalesnik J, Mysliwiec A, Canby-Hagino E. Anemia in men with advanced prostate cancer: Incidence, etiology, and treatment. Rev Urol 2004; 6:1–4.
    • (2004) Rev Urol , vol.6 , pp. 1-4
    • Nalesnik, J.1    Mysliwiec, A.2    Canby-Hagino, E.3
  • 15
    • 77953311958 scopus 로고    scopus 로고
    • Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
    • Nieder C, Haukland E, Pawinski A, Dalhaug A. Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases. BMC Cancer 2010; 10:284.
    • (2010) BMC Cancer , vol.10 , pp. 284
    • Nieder, C.1    Haukland, E.2    Pawinski, A.3    Dalhaug, A.4
  • 16
    • 84982310631 scopus 로고    scopus 로고
    • ERA223: A phase 3 trial of radium-223 dichloride in combination with abiraterone acetate and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients with bone predominant metastatic castration-resistant prostate cancer
    • Abstr TPS5082
    • Smith M, Parker C, Tombal B, Miller K, Saad F, Fang F, Zhang A, Kornacker M, Higano CS. ERA223: A phase 3 trial of radium-223 dichloride in combination with abiraterone acetate and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients with bone predominant metastatic castration-resistant prostate cancer. J Clin Oncol 2015; 33: Abstr TPS5082.
    • (2015) J Clin Oncol , vol.33
    • Smith, M.1    Parker, C.2    Tombal, B.3    Miller, K.4    Saad, F.5    Fang, F.6    Zhang, A.7    Kornacker, M.8    Higano, C.S.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.